synthesis of catecholemines
Tyrosine –enzyme (TH)–> L-DOPA –enzyme (AADC)–> Dopamine – enzyme (DBH)–> Norepinephrine –enzyme (PNMT)–> Epinephrine
dopaminergic system organization
The dopaminergic system is organized into three main ascending pathways (nigrostriatal, mesolimbic, mesocortical) originating from the substantia nigra and VTA, with additional smaller systems in the hypothalamus and sensory structures.
Dopaminergic system function
dopamine
regulates movement,
reward
motivation,
learning
cognitive functioning
dysfunction in specific pathways contributing to disorders such as Parkinson’s disease, schizophrenia, addiction, and ADHD.
noradrenergic system organization
major norepinephrine (NE) system in the brain, neurons in the locus coeruleus (LC) in the pons. It sends widespread projections upward (“ascending”) to almost the entire forebrain.
noradrenergic system function
It regulates:
- Arousal and wakefulness
- attention and working memory, prefrontal cortex
- sensory processing
- emotion, learning and memory
- stress & fight/flight response
three catecholamine neurotransmitters
dopamine DA
epinephrine
Norepinephrine NE
2 dopaminergic pathways
1) Nigrostriatal Pathway: Coordinates movement; DA loss = rigidity, tremor.
2) Mesolimbic Pathway: Reinforces pleasure, emotion, motivation.
Mesocortical Pathway: Supports higher thinking and planning.
Parkinson’s disease
Parkinson’s disease involves a massive loss of DA neurons in the substantia nigra and consequent DA denervation of the dorsal striatum. Characterized by progressive motor dysfunction, typically beginning with tremors and advancing to postural disturbances, akinesia (lack of movement), and rigidity
two major families of dopamine receptors
D1-like receptors (which include D1 and D5) increase the activity of the enzyme adenylyl cyclase, which raises levels of cAMP inside the cell and neuron more active or excited.
D2-like receptors (which include D2, D3, and D4) do the opposite — they inhibit adenylyl cyclase and lower cAMP levels, which makes the neuron less active or inhibited.
what do adrenergic agonists do
activate α- and/or β-adrenergic receptors, mimicking the actions of norepinephrine and epinephrine producing sympathetic effects like vasoconstriction, bronchodilation, increased heart rate, and reduced NE release (α2).
how are adrenergic drugs useful in treating medical conditions
What amino acid are catecholamines derived from?
Tyrosine
What enzyme converts tyrosine into L-DOPA?
Tyrosine hydroxylase (TH)
the rate-limiting enzyme in catecholamine synthesis
Tyrosine hydroxylase (TH)
What is the product of tyrosine hydroxylase acting on tyrosine?
L-DOPA (L-dihydroxyphenylalanine)
What enzyme converts L-DOPA to dopamine (DA)?
Aromatic L-amino acid decarboxylase (AADC) — removes a carboxyl group.
What enzyme converts dopamine to norepinephrine (NE)?
Dopamine β-hydroxylase (DBH) — adds a hydroxyl group to dopamine.
What enzyme converts norepinephrine to epinephrine (EPI)?
Phenylethanolamine N-methyltransferase (PNMT) — adds a methyl group.
Where does conversion from norepinephrine to epinephrine occur?
Mainly in the adrenal medulla and some brainstem neurons.
Neurons with only TH and AADC produce which neurotransmitter?
Dopamine (DA) → These are dopaminergic neurons.
Neurons with TH, AADC, and DBH produce which neurotransmitter?
Norepinephrine (NE) → Noradrenergic neurons.
Cells that contain all four enzymes (TH, AADC, DBH, PNMT) produce which neurotransmitter?
Epinephrine (EPI) → Mainly in adrenal medulla cells.
How do high levels of dopamine or norepinephrine affect TH?
They inhibit TH activity through negative feedback, slowing synthesis.
Where is catecholamine synthesis greatest in the neuron?
At the nerve terminal, near synaptic vesicles — for rapid refilling.